504 related articles for article (PubMed ID: 36191689)
21. Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study.
Bussmann C; Maintz L; Hart J; Allam JP; Vrtala S; Chen KW; Bieber T; Thomas WR; Valenta R; Zuberbier T; Sager A; Novak N
Clin Exp Allergy; 2007 Sep; 37(9):1277-85. PubMed ID: 17845407
[TBL] [Abstract][Full Text] [Related]
22. Specific allergen immunotherapy for the treatment of atopic eczema: a Cochrane systematic review.
Tam HH; Calderon MA; Manikam L; Nankervis H; Núñez IG; Williams HC; Durham SR; Boyle RJ
Allergy; 2016 Sep; 71(9):1345-56. PubMed ID: 27184158
[TBL] [Abstract][Full Text] [Related]
23. Compromising between European and US allergen immunotherapy schools: Discussions from GUIMIT, the Mexican immunotherapy guidelines.
Larenas-Linnemann D; Rodríguez-Pérez N; Luna-Pech JA; Rodríguez-González M; Blandón-Vijil MV; Del-Río-Navarro BE; Costa-Domínguez MDC; Navarrete-Rodríguez EM; Macouzet-Sánchez C; Ortega-Martell JA; Pozo-Beltrán CF; Estrada-Cardona A; Arias-Cruz A; Rodríguez Galván KG; Brito-Díaz H; Canseco-Raymundo MDR; Castelán-Chávez EE; Escalante-Domínguez AJ; Gálvez-Romero JL; Gómez-Vera J; González-Díaz SN; Guerrero-Núñez MGB; Hernández-Colín DD; Macías-Weinmann A; Mendoza-Hernández DA; Meneses-Sánchez NA; Mogica-Martínez MD; Moncayo-Coello CV; Montiel-Herrera JM; O'Farril-Romanillos PM; Onuma-Takane E; Ortega-Cisneros M; Rangel-Garza L; Stone-Aguilar H; Torres-Lozano C; Venegas-Montoya E; Wakida-Kusunoki G; Partida-Gaytán A; López-García AI; Macías-Robles AP; Ambriz-Moreno MJ; Azamar-Jácome AA; Beltrán-De Paz CY; Caballero-López C; Fernández de Córdova-Aguirre JC; Fernández-Soto JR; Lozano-Sáenz JS; Oyoqui-Flores JJ; Osorio-Escamilla RE; Ramírez-Jiménez F; Rivero-Yeverino D; Martínez Infante E; Medina-Ávalos MA
World Allergy Organ J; 2020 Aug; 13(8):100444. PubMed ID: 32884611
[TBL] [Abstract][Full Text] [Related]
24. Methods for Experimental Allergen Immunotherapy: Subcutaneous and Sublingual Desensitization in Mouse Models of Allergic Asthma.
Hesse L; Petersen AH; Nawijn MC
Methods Mol Biol; 2021; 2223():295-335. PubMed ID: 33226602
[TBL] [Abstract][Full Text] [Related]
25. Selection of patients for sublingual versus subcutaneous immunotherapy.
Larenas Linnemann DE; Blaiss MS
Immunotherapy; 2014; 6(7):871-84. PubMed ID: 25290418
[TBL] [Abstract][Full Text] [Related]
26. Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations.
; Chu DK; Schneider L; Asiniwasis RN; Boguniewicz M; De Benedetto A; Ellison K; Frazier WT; Greenhawt M; Huynh J; Kim E; LeBovidge J; Lind ML; Lio P; Martin SA; O'Brien M; Ong PY; Silverberg JI; Spergel JM; Wang J; Wheeler KE; Guyatt GH; ; Capozza K; ; Begolka WS; ; Chu AWL; Zhao IX; Chen L; Oykhman P; Bakaa L; ; Golden D; Shaker M; Bernstein JA; Greenhawt M; Horner CC; Lieberman J; Stukus D; Rank MA; Wang J; Ellis A; Abrams E; Ledford D; Chu DK
Ann Allergy Asthma Immunol; 2024 Mar; 132(3):274-312. PubMed ID: 38108679
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness of subcutaneous versus sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review.
Chelladurai Y; Suarez-Cuervo C; Erekosima N; Kim JM; Ramanathan M; Segal JB; Lin SY
J Allergy Clin Immunol Pract; 2013; 1(4):361-9. PubMed ID: 24565541
[TBL] [Abstract][Full Text] [Related]
28. Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study.
Pajno GB; Caminiti L; Vita D; Barberio G; Salzano G; Lombardo F; Canonica GW; Passalacqua G
J Allergy Clin Immunol; 2007 Jul; 120(1):164-70. PubMed ID: 17543376
[TBL] [Abstract][Full Text] [Related]
29. Principles of Allergen Immunotherapy and Its Clinical Application in China: Contrasts and Comparisons with the USA.
Guan K; Liu B; Wang M; Li Z; Chang C; Cui L; Wang RQ; Wen LP; Leung PSC; Wei JF; Sun JL
Clin Rev Allergy Immunol; 2019 Aug; 57(1):128-143. PubMed ID: 31243705
[TBL] [Abstract][Full Text] [Related]
30. Bleach baths for atopic dermatitis: A systematic review and meta-analysis including unpublished data, Bayesian interpretation, and GRADE.
Bakaa L; Pernica JM; Couban RJ; Tackett KJ; Burkhart CN; Leins L; Smart J; Garcia-Romero MT; Elizalde-Jiménez IG; Herd M; Asiniwasis RN; Boguniewicz M; De Benedetto A; Chen L; Ellison K; Frazier W; Greenhawt M; Huynh J; LeBovidge J; Lind ML; Lio P; O'Brien M; Ong PY; Silverberg JI; Spergel JM; Wang J; Begolka WS; Schneider L; Chu DK
Ann Allergy Asthma Immunol; 2022 Jun; 128(6):660-668.e9. PubMed ID: 35367346
[TBL] [Abstract][Full Text] [Related]
31. [Allergen immunotherapy for atopic dermatitis].
Traidl S; Werfel T
Hautarzt; 2021 Dec; 72(12):1103-1112. PubMed ID: 34792615
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness analysis of house dust mite allergen immunotherapy in children with allergic asthma.
Farraia M; Paciência I; Castro Mendes F; Cavaleiro Rufo J; H Shamji M; Agache I; Moreira A
Allergy; 2022 Sep; 77(9):2688-2698. PubMed ID: 35451128
[TBL] [Abstract][Full Text] [Related]
33. Current advances in house dust mite allergen immunotherapy (AIT): Routes of administration, biomarkers and molecular allergen profiling.
Batard T; Canonica WG; Pfaar O; Shamji MH; O'Hehir RE; van Zelm MC; Mascarell L
Mol Immunol; 2023 Mar; 155():124-134. PubMed ID: 36806944
[TBL] [Abstract][Full Text] [Related]
34. House dust mite SCIT reduces asthma risk and significantly improves long-term rhinitis and asthma control-A RWE study.
Jutel M; Klimek L; Richter H; Brüggenjürgen B; Vogelberg C
Allergy; 2024 Apr; 79(4):1042-1051. PubMed ID: 38429981
[TBL] [Abstract][Full Text] [Related]
35. Is immunotherapy safe for treatment of severe asthma.
Epstein TEG; Calabria CW
Curr Opin Allergy Clin Immunol; 2022 Dec; 22(6):396-401. PubMed ID: 36305469
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma: A Randomized Clinical Trial.
Virchow JC; Backer V; Kuna P; Prieto L; Nolte H; Villesen HH; Ljørring C; Riis B; de Blay F
JAMA; 2016 Apr; 315(16):1715-25. PubMed ID: 27115376
[TBL] [Abstract][Full Text] [Related]
37. Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial.
Eifan AO; Akkoc T; Yildiz A; Keles S; Ozdemir C; Bahceciler NN; Barlan IB
Clin Exp Allergy; 2010 Jun; 40(6):922-32. PubMed ID: 20100188
[TBL] [Abstract][Full Text] [Related]
38. Immunotherapy of house dust mite allergy.
Yang L; Zhu R
Hum Vaccin Immunother; 2017 Oct; 13(10):2390-2396. PubMed ID: 28853977
[TBL] [Abstract][Full Text] [Related]
39. Subcutaneous and Sublingual Immunotherapy in a Mouse Model of Allergic Asthma.
Hesse L; Nawijn MC
Methods Mol Biol; 2017; 1559():137-168. PubMed ID: 28063043
[TBL] [Abstract][Full Text] [Related]
40. Clinical Efficacy of Subcutaneous Allergen Immunotherapy in Patients with Atopic Dermatitis.
Nahm DH; Kim ME; Kwon B; Cho SM; Ahn A
Yonsei Med J; 2016 Nov; 57(6):1420-6. PubMed ID: 27593870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
